The Mukobohaterowie Foundation has turned to the RPO regarding access to medicines for people with cystic fibrosis. At issue is an announcement by the Ministry of Health, according to which some drugs used in the treatment of cystic fibrosis are not financed under emergency access to drug technologies.
According to the MZ Announcement of October 20, 2023 on the list of reimbursed drugs, foodstuffs for special nutritional purposes and medical devices as of November 1, 2023 under the drug program , "B.112. TREATMENT OF CANCER DISEASE (ICD-10: E84)", public funding is available for some patients. The introduction of treatment for new groups of patients requires consideration of a new reimbursement application.
A pharmaceutical company applied for reimburse...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
